Lesabelimab, CAS 2475402-56-1

Product Description: Lesabelimab (LDP) is an immunoglobulin G1-kappa anti-CD274 monoclonal antibody. CD274 is an immune checkpoint ligand, represses antitumour immunity through the interaction with PDCD1 receptor[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 35, No. 4, 2021./[2]Masugi Y, et al. Tumour CD274 (PD-L1) expression and T cells in colorectal cancer. Gut. 2017 Aug;66(8):1463-1473.

CAS Number: 2475402-56-1

Molecular Weight: N/A

Compound Purity: 97.34

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Others

• SKU: MEXHY-P99698-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99698-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated